Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
Xiaoling XuMingfeng HanTiantian LiWei SunDongsheng WangBinqing FuYonggang ZhouXiaohu ZhengYun YangXiuyong LiXiaohua ZhangAijun PanHaiming WeiPublished in: Proceedings of the National Academy of Sciences of the United States of America (2020)